Release of prostacyclin into the bloodstream and its exhaustion in humans after local blood flow changes (ischemia and venous stasis)
- 31 December 1979
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 17 (1-2) , 197-208
- https://doi.org/10.1016/0049-3848(80)90306-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The effects of prostacyclin (PGI2) on tissues which detect prostaglandins (PG'S)Prostaglandins, 1977
- Bioassay by cascade superfusion using a highly sensitive laminar flow techniqueJournal of Pharmacy and Pharmacology, 1977
- Prostacyclin (PGX) is the endogeneous metabolite responsible for relaxation of coronary arteries induced by arachidonic acidProstaglandins, 1977
- HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATIONThe Lancet, 1977
- The chemical structure of prostaglandin X (prostacyclin)Prostaglandins, 1976
- A laminar flow superfusion technique with much increased sensitivity for the detection of smooth muscle-stimulating substancesEuropean Journal of Pharmacology, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Hypoxia Causes Prostaglandin Release from Perfused Rabbit HeartsActa Physiologica Scandinavica, 1974
- Prostaglandin-Like Substances Appearing in Canine Renal Venous Blood During Renal IschemiaCirculation Research, 1970
- The release and fate of vaso‐active hormones in the circulationBritish Journal of Pharmacology, 1969